Geode Capital Management, LLC Reviva Pharmaceuticals Holdings, Inc. Transaction History
Geode Capital Management, LLC
- $1.12 Trillion
- Q2 2024
A detailed history of Geode Capital Management, LLC transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 236,120 shares of RVPH stock, worth $224,314. This represents 0.0% of its overall portfolio holdings.
Number of Shares
236,120
Previous 220,117
7.27%
Holding current value
$224,314
Previous $832,000
63.7%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding RVPH
# of Institutions
39Shares Held
6.77MCall Options Held
256KPut Options Held
77.1K-
Woodline Partners LP San Francisco, CA1.59MShares$1.51 Million0.02% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.24MShares$1.18 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$973,9860.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY1.01MShares$963,1010.01% of portfolio
-
Parkman Healthcare Partners LLC Stamford, CT505KShares$479,3700.1% of portfolio
About REVIVA PHARMACEUTICALS HOLDINGS, INC.
- Ticker RVPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,442,900
- Market Cap $19.4M
- Description
- Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...